CD24 plays an important role in the carcinogenesis process of the pancreas

Biomedicine and Pharmacotherapy

Volumn 60, Issue 6, 2006, Pages 280-284

  Sagiv, E ^a,b   Kazanov, D ^a   Arber, N ^a,b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

CD24; Monoclonal antibodies; Pancreatic cancer

Indexed keywords

CD24 ANTIGEN; GREEN FLUORESCENT PROTEIN; MONOCLONAL ANTIBODY;

ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; WESTERN BLOTTING; APOPTOSIS; CELL PROLIFERATION; DRUG EFFECT; IMMUNOLOGY; METABOLISM; PANCREAS TUMOR; TUMOR CELL LINE;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD24; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; PANCREATIC NEOPLASMS;

EID: 33747138600     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2006.06.006     Document Type: Article

References (22)

1. Jeong S., Lee D.H., Lee J.I., Lee J.W., Kwon K.S., Kim P.S., et al. Expression of Ki-67, p53, and K-ras in chronic pancreatitis and pancreatic ductal adenocarcinoma. World J. Gastroenterol. 11 (2005) 6765-6769
2. Warshaw A.L., and Fernandez-del Castillo C. Pancreatic carcinoma. N. Engl. J. Med. 326 (1992) 455-465
3. Boyle P., Hsieh C.C., Maisonneuve P., La Vecchia C., Macfarlane G.J., Walker A.M., et al. Epidemiology of pancreas cancer (1988). Int. J. Pancreatol. 5 (1989) 327-346
4. Wingo P.A., Tong T., and Bolden S. Cancer statistics, 1995. CA Cancer J. Clin. 45 (1995) 8-30
5. Crist D.W., and Cameron J.L. The current status of the Whipple operation for periampullary carcinoma. Adv. Surg. 25 (1992) 21-49
6. Taguchi T., Kiyokawa N., Mimori K., Suzuki T., Sekino T., Nakajima H., et al. Pre-B cell antigen receptor-mediated signal inhibits CD24-induced apoptosis in human pre-B cells. J. Immunol. 170 (2003) 252-260
7. Jung K.C., Park W.S., Kim H.J., Choi E.Y., Kook M.C., Lee H.W., et al. TCR-independent and caspase-independent apoptosis of murine thymocytes by CD24 cross-linking. J. Immunol. 172 (2004) 795-802
8. Kristiansen G., Sammar M., and Altevogt P. Tumor biological aspects of CD24, a mucin-like adhesion molecule. J. Mol. Histol. 35 (2004) 255-262
9. Suzuki T., Kiyokawa N., Taguchi T., Sekino T., Katagiri Y.U., and Fujimoto J. CD24 induces apoptosis in human B cells via the glycolipid-enriched membrane domains/rafts-mediated signaling system. J. Immunol. 166 (2001) 5567-5577
10. Kadmon G., Von Bohlen F., Halbach, Schachner M., and Altevogt P. LFA-1-sensitive effects of antibodies to nectadrin, the heat stable antigen, on B-lymphoblast aggregation and signal transduction. Biochem. Biophys. Res. Commun. 198 (1994) 1209-1215
11. Poncet C., Frances V., Gristina R., Scheiner C., Pellissier J.F., and Figarella-Branger D. CD24, a glycosylphosphatidylinositol-anchored molecule, is transiently expressed during the development of human central nervous system and is a marker of human neural cell lineage tumors. Acta Neuropathol. (Berl.) 91 (1996) 400-408
12. Friederichs J., Zeller Y., Hafezi-Moghadam A., Grone H.J., Ley K., and Altevogt P. The CD24/P-selectin binding pathway initiates lung arrest of human A125 adenocarcinoma cells. Cancer Res. 60 (2000) 6714-6722
13. Kristiansen G., Winzer K.J., Mayordomo E., Bellach J., Schluns K., Denkert C., et al. CD24 expression is a new prognostic marker in breast cancer. Clin. Cancer Res. 9 (2003) 4906-4913
14. Kristiansen G., Pilarsky C., Pervan J., Sturzebecher B., Stephan C., Jung K., et al. CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer. Prostate 58 (2004) 183-192
15. Jurg A., Zarn, Sandra M., Zimmermann, Pass M.K., Waibel R., and Stahel R.A. Association of CD24 with the kinase c-fgr in a small cell lung cancer cell line and with the kinase lyn in an erythroleukemia cell line. Biochem. Biophys. Res. Commun. 225 (1996) 384-391
16. Welsh J.B., Zarrinkar P.P., Sapinoso L.M., Kern S.G., Behling C.A., Monk B.J., et al. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc. Natl. Acad. Sci. USA 98 (2001) 1176-1181
17. Senner V., Sturm A., Baur I., Schrell U.H., Distel L., and Paulus W. CD24 promotes invasion of glioma cells in vivo. J. Neuropathol. Exp. Neurol. 58 (1999) 795-802
18. Huang L.R., and Hsu H.C. Cloning and expression of CD24 gene in human hepatocellular carcinoma: a potential early tumor marker gene correlates with p53 mutation and tumor differentiation. Cancer Res. 55 (1995) 4717-4721
19. Cram D.S., McIntosh A., Oxbrow L., Johnston A.M., and DeAizpurua H.J. Differential mRNA display analysis of two related but functionally distinct rat insulinoma (RIN) cell lines: identification of CD24 and its expression in the developing pancreas. Differentiation 64 (1999) 237-246
20. Han H., Bearss D.J., Browne L.W., Calaluce R., Nagle R.B., and Von Hoff D.D. Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res. 62 (2002) 2890-2896
21. Jacob J., Bellach J., Grutzmann R., Alldinger I., Pilarski C., Dietel M., et al. Expression of CD24 in adenocarcinomas of the pancreas correlates with higher tumor grades. Pancreatol. 4 (2004) 454-460
22. Aigner S., Sthoeger Z.M., Fogel M., Weber E., Zarn J., Ruppert M., et al. CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells. Blood 89 (1997) 3385-3395